KEY DIFFERENCES BETWEEN CATHINONES AND BZP

‘Designer drugs’: update to the management of novel psychoactive compound misuse in the acute treatment settingThe toxicity and long-term wellbeing consequences of recreational N-ethylhexedrone use never seem to have been examined in almost any scientific context and the exact harmful dosage is unfamiliar. It is because N-ethylhexedrone has an